SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001214659-24-010877
Filing Date
2024-06-12
Accepted
2024-06-12 17:14:25
Documents
1
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-66337.html 3/A  
1 PRIMARY DOCUMENT marketforms-66337.xml 3/A 2764
  Complete submission text file 0001214659-24-010877.txt   4305
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AQUESTIVE THERAPUETICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Korczynski Sherry (Reporting) CIK: 0002026090 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38599 | Film No.: 241039282